Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis
- 29 January 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (4), 106311
- https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106311
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in GermanyAnnals of Neurology, 2021
- Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines AgencyEuropean Journal of Neurology, 2021
- Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia—VITTJournal of Clinical Medicine, 2021
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic ThrombocytopeniaThe New England Journal of Medicine, 2021
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationThe New England Journal of Medicine, 2021
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 VaccinationThe New England Journal of Medicine, 2021
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort studyBMJ, 2021
- Prothrombotic immune thrombocytopenia after COVID-19 vaccinationBlood, 2021
- Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHHämostaseologie, 2021